6305 related articles for article (PubMed ID: 3405342)
1. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. IV. Therapy of murine melanoma B16 by human serum albumin-methotrexate derivative.
Bostík J; Bures L; Spundová M
Neoplasma; 1988; 35(3):343-9. PubMed ID: 3405342
[TBL] [Abstract][Full Text] [Related]
2. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
Bures L; Bostík J; Motycka K; Spundová M; Rehák L
Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
4. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
Chu BC; Whiteley JM
J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
[TBL] [Abstract][Full Text] [Related]
5. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative.
Bures L; Motycka K; Bostík J; Slavík K; Jirásek A
Neoplasma; 1986; 33(4):409-16. PubMed ID: 3762803
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
[TBL] [Abstract][Full Text] [Related]
7. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
8. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. V. Alternative method for preparation of serum albumin-methotrexate derivative.
Bures L; Lichý A; Bostík J; Spundová M
Neoplasma; 1990; 37(3):225-31. PubMed ID: 2370913
[TBL] [Abstract][Full Text] [Related]
9. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX.
Fiehn C; Müller-Ladner U; Gay S; Krienke S; Freudenberg-Konrad S; Funk J; Ho AD; Sinn H; Wunder A
Rheumatology (Oxford); 2004 Sep; 43(9):1097-105. PubMed ID: 15199219
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo.
Fiehn C; Neumann E; Wunder A; Krienke S; Gay S; Müller-Ladner U
Ann Rheum Dis; 2004 Jul; 63(7):884-6. PubMed ID: 15194591
[TBL] [Abstract][Full Text] [Related]
11. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
Taheri A; Dinarvand R; Ahadi F; Khorramizadeh MR; Atyabi F
Int J Pharm; 2012 Jul; 431(1-2):183-9. PubMed ID: 22531853
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease.
Wolff D; Frei E; Hofmeister N; Steiner B; Kleine HD; Junghanss C; Sievert K; Terpe H; Schrenk HH; Freund M; Hartung G
Transplantation; 2006 Aug; 82(4):527-33. PubMed ID: 16926597
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy.
Vis AN; van der Gaast A; van Rhijn BW; Catsburg TK; Schmidt C; Mickisch GH
Cancer Chemother Pharmacol; 2002 Apr; 49(4):342-5. PubMed ID: 11914915
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival of renal allograft in rats by methotrexate-albumin conjugates as immunosuppressive therapy.
Hickstein H; Wolff D; Stange J; Frei E; Hartung G
Transplant Proc; 2008 Dec; 40(10):3725-7. PubMed ID: 19100475
[TBL] [Abstract][Full Text] [Related]
16. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
Motycka K; Slavík K; Dyr JE; Balcarová A; Vodrázka Z
Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104
[TBL] [Abstract][Full Text] [Related]
17. Hormonal influences on growth of B16 murine melanoma.
Simon SR; Ershler WB
J Natl Cancer Inst; 1985 May; 74(5):1085-8. PubMed ID: 3858578
[TBL] [Abstract][Full Text] [Related]
18. Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis.
Fiehn C; Kratz F; Sass G; Müller-Ladner U; Neumann E
Ann Rheum Dis; 2008 Aug; 67(8):1188-91. PubMed ID: 18408252
[TBL] [Abstract][Full Text] [Related]
19. Slower B16 melanoma growth but greater pulmonary colonization in calorie-restricted mice.
Ershler WB; Berman E; Moore AL
J Natl Cancer Inst; 1986 Jan; 76(1):81-5. PubMed ID: 3455745
[TBL] [Abstract][Full Text] [Related]
20. Localization and distribution of magnetic chemotherapeutic drugs with magnetic targeting in rat brain.
Li AM; Zhang CX; Fu XP; Zhang ZW; Xue QH; Yan RM; Yi LH
Chin Med J (Engl); 2005 May; 118(10):824-7. PubMed ID: 15989762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
